|
Site-Search: Home : |
: Alzheimer-Disease: The Alzheimer Association projects that by 2025 more than 22 million people worldwide may be diagnosed with AD. Melissa: Melissa, officinalis,
is effective in a placebo-control study, for four months with 42 patients
with mild-to-moderate Alzheimer's disease. Melissa, officinalis
treatment gives significant improvements in cognitive Salvia: Preclinical studies of both Melissa, officinalis (lemonbalm) and Salvia, officinalis (sage) show that their mechanism and potency are similar to FDA-approved medications for Alzheimer disease. Ginkgo: Ginkgo, biloba has been shown to improve cognitive test scores in Alzheimer-disease. Many of theose who fail to show improvement in the first month improve with continuing supplementation. L-Carnosine: L-Carnosine is neuroprotective against free radicals, excitotoxins (e.g. glutamate) and advanced glycation endproducts (A.G.E.). Body-Mass-Index: BMI is weight in kilograms divided by the square of height in meters, or weight in pounds divided by height in inches squared, times 703.
Research at Utah State University
finds women in the high overweight to obese range have a higher risk
of Alzheimer's disease. At age 70, each 1.0 increase of BMI may raise
AD risk by 36 percent. On average, women who develop dementia have
a BMI two to three points higher than healthy women. There was no
statistical correlation between BMI and Alzheimer's risk for men. Vascular factors also contribute to Alzheimer's risk. |
|||||||||
|
: :Issues :Solutions :Biofield :Training :Starfire :Catalog :Order For
all Claims by this Ministry: wizardofeyez are with the Vacancy
of any Claim by any Ministry of this World. For the
Volition of this Ministry is for our Self-Healing of each
Body, Mind and Soul with the Freedom of the Communication
of all Truth by the Authority and Grace of our Sovereign-King
of all Kings of this Kingdom of the Heavens. :SITE-COPYCLAIM-©: 9/8/2001, A.D., with the Freedom against the Egypt-Calendar: G. M. Swartwout© |
||||||||||